{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:32:57Z","timestamp":1793471577287,"version":"4.5.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1038\/s41584-024-01155-z","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:02:34Z","timestamp":1725602554000},"page":"671-682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["An interdisciplinary perspective on peripheral drivers of pain in rheumatoid arthritis"],"prefix":"10.1038","volume":"20","author":[{"given":"Zoe","family":"Rutter-Locher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-3574","authenticated-orcid":false,"given":"Kirsty","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-2696","authenticated-orcid":false,"given":"David L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-6402","authenticated-orcid":false,"given":"Christopher D.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9337-7194","authenticated-orcid":false,"given":"Leonie S.","family":"Taams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-4234","authenticated-orcid":false,"given":"Franziska","family":"Denk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"1155_CR1","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/ejp.1651","volume":"24","author":"P Vergne-Salle","year":"2020","unstructured":"Vergne-Salle, P. et al. The burden of pain in rheumatoid arthritis: impact of disease activity and psychological factors. Eur. J. Pain. 24, 1979\u20131989 (2020).","journal-title":"Eur. J. Pain."},{"key":"1155_CR2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/03009742.2020.1729404","volume":"49","author":"B Svensson","year":"2020","unstructured":"Svensson, B., Forslind, K. & Andersson, M. Unacceptable pain in the BARFOT inception cohort of patients with rheumatoid arthritis: a long-term study. Scand. J. Rheumatol. 49, 371-378, (2020).","journal-title":"Scand. J. Rheumatol."},{"key":"1155_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","volume":"44","author":"F Matcham","year":"2014","unstructured":"Matcham, F. et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin. Arthritis Rheum. 44, 123\u2013130 (2014).","journal-title":"Semin. Arthritis Rheum."},{"key":"1155_CR4","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","volume":"52","author":"F Matcham","year":"2013","unstructured":"Matcham, F., Rayner, L., Steer, S. & Hotopf, M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 52, 2136\u20132148 (2013).","journal-title":"Rheumatology"},{"key":"1155_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10067-013-2477-y","volume":"34","author":"G Bagnato","year":"2015","unstructured":"Bagnato, G. et al. Pain threshold and intensity in rheumatic patients: correlations with the Hamilton Depression Rating scale. Clin. Rheumatol. 34, 555\u2013561 (2015).","journal-title":"Clin. Rheumatol."},{"key":"1155_CR6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/rheumatology\/39.12.1403","volume":"39","author":"EM Barrett","year":"2000","unstructured":"Barrett, E. M., Scott, D. G. I., Wiles, N. J. & Symmons, D. P. M. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology 39, 1403\u20131409 (2000).","journal-title":"Rheumatology"},{"key":"1155_CR7","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/acr.23619","volume":"70","author":"T Olofsson","year":"2018","unstructured":"Olofsson, T., S\u00f6derling, J. K., G\u00fclfe, A., Kristensen, L. E. & Wallman, J. K. Patient-reported outcomes are more important than objective inflammatory markers for sick leave in biologics-treated patients with rheumatoid arthritis. Arthritis Care Res. 70, 1712\u20131716 (2018).","journal-title":"Arthritis Care Res."},{"key":"1155_CR8","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Prim. 4, 18001\u201318001 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1155_CR9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester, G. R. & Pope, J. E. Novel treatment strategies in rheumatoid arthritis. Lancet 389, 2338\u20132348 (2017).","journal-title":"Lancet"},{"key":"1155_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41927-019-0054-y","volume":"3","author":"NJ Gullick","year":"2019","unstructured":"Gullick, N. J. et al. Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis. BMC Rheumatol. 3, 6 (2019).","journal-title":"BMC Rheumatol."},{"key":"1155_CR11","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar3353","volume":"13","author":"YC Lee","year":"2011","unstructured":"Lee, Y. C. et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR\/EULAR remission: a longitudinal observational study. Arthritis Res. Ther. 13, R83\u2013R83 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jpain.2019.01.001","volume":"20","author":"DF McWilliams","year":"2019","unstructured":"McWilliams, D. F. et al. Discrete trajectories of resolving and persistent pain in people with rheumatoid arthritis despite undergoing treatment for inflammation: results from three UK cohorts. J. Pain. 20, 716\u2013727 (2019).","journal-title":"J. Pain."},{"key":"1155_CR13","first-page":"314","volume":"35","author":"L Cunha-Miranda","year":"2010","unstructured":"Cunha-Miranda, L., Costa, L. & Ribeiro, J. S. NEAR study: needs and expectations in rheumatoid arthritis \u2014 do we know our patients needs? Acta Reumatol. Port. 35, 314\u2013323 (2010).","journal-title":"Acta Reumatol. Port."},{"key":"1155_CR14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/acr.20005","volume":"62","author":"D Borenstein","year":"2010","unstructured":"Borenstein, D. et al. Report of the American College of Rheumatology pain management task force. Arthritis Care Res. 62, 590\u2013599 (2010).","journal-title":"Arthritis Care Res."},{"key":"1155_CR15","unstructured":"Versus Arthritis. A research roadmap for pain. https:\/\/www.versusarthritis.org\/media\/1672\/research-roadmap-pain.pdf (2018)."},{"key":"1155_CR16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.42429","volume":"75","author":"F Sunzini","year":"2023","unstructured":"Sunzini, F., Schrepf, A., Clauw, D. J. & Basu, N. The biology of pain: through the rheumatology lens. Arthritis Rheumatol. 75, 650\u2013660 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1155_CR17","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/acr.22097","volume":"65","author":"RJ Stack","year":"2013","unstructured":"Stack, R. J., Sahni, M., Mallen, C. D. & Raza, K. Symptom complexes at the earliest phases of rheumatoid arthritis: a synthesis of the qualitative literature. Arthritis Care Res. 65, 1916\u20131926 (2013).","journal-title":"Arthritis Care Res."},{"key":"1155_CR18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.44.4.262","volume":"44","author":"S Wagstaff","year":"1985","unstructured":"Wagstaff, S., Smith, O. V. & Wood, P. H. Verbal pain descriptors used by patients with arthritis. Ann. Rheum. Dis. 44, 262\u2013265 (1985).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR19","doi-asserted-by":"crossref","DOI":"10.1111\/hex.14090","volume":"27","author":"Z Rutter-Locher","year":"2024","unstructured":"Rutter-Locher, Z. et al. Comparative analysis of centrally mediated and inflammatory pain experiences amongst patients diagnosed with rheumatoid arthritis: a multimethods study. Health Expect. 27, e14090 (2024).","journal-title":"Health Expect."},{"key":"1155_CR20","doi-asserted-by":"crossref","first-page":"152207","DOI":"10.1016\/j.semarthrit.2023.152207","volume":"61","author":"Z Rutter-Locher","year":"2023","unstructured":"Rutter-Locher, Z. et al. A systematic review and meta-analysis of questionnaires to screen for pain sensitisation and neuropathic like pain in inflammatory arthritis. Semin. Arthritis Rheum. 61, 152207 (2023).","journal-title":"Semin. Arthritis Rheum."},{"key":"1155_CR21","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J. S., Aletaha, D. & McInnes, I. B. Rheumatoid arthritis. Lancet 388, 2023\u20132038 (2016).","journal-title":"Lancet"},{"key":"1155_CR22","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes, I. B. & Schett, G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389, 2328\u20132337 (2017).","journal-title":"Lancet"},{"key":"1155_CR23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11914-018-0473-5","volume":"16","author":"A Zhang","year":"2018","unstructured":"Zhang, A. & Lee, Y. C. Mechanisms for joint pain in rheumatoid arthritis (RA): from cytokines to central sensitization. Curr. Osteoporos. Rep. 16, 603\u2013610 (2018).","journal-title":"Curr. Osteoporos. Rep."},{"key":"1155_CR24","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","volume":"54","author":"SB Cohen","year":"2006","unstructured":"Cohen, S. B. et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum. 54, 2793\u20132806 (2006).","journal-title":"Arthritis Rheum."},{"key":"1155_CR25","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"R Maini","year":"1999","unstructured":"Maini, R. et al. Infliximab (chimeric anti-tumour necrosis factor \u03b1 monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 354, 1932\u20131939 (1999).","journal-title":"Lancet"},{"key":"1155_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt, M. E. et al. Adalimumab, a fully human anti-tumor necrosis factor \u03b1 monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 48, 35\u201345 (2003).","journal-title":"Arthritis Rheum."},{"key":"1155_CR27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2020.10.008","volume":"51","author":"LS Simon","year":"2021","unstructured":"Simon, L. S. et al. The Jak\/STAT pathway: a focus on pain in rheumatoid arthritis. Semin. Arthritis Rheum. 51, 278\u2013284 (2021).","journal-title":"Semin. Arthritis Rheum."},{"key":"1155_CR28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13075-018-1610-3","volume":"20","author":"IB McInnes","year":"2018","unstructured":"McInnes, I. B. et al. Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study. Arthritis Res. Ther. 20, 113 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-021-02550-7","volume":"23","author":"A Eberhard","year":"2021","unstructured":"Eberhard, A. et al. Predictors of unacceptable pain with and without low inflammation over 5\u2009years in early rheumatoid arthritis \u2014 an inception cohort study. Arthritis Res. Ther. 23, 169\u2013169 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR30","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003784","volume":"10","author":"K Chaabo","year":"2024","unstructured":"Chaabo, K. et al. Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis. RMD Open. 10, e003784 (2024).","journal-title":"RMD Open."},{"key":"1155_CR31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrrheum.2014.64","volume":"10","author":"DA Walsh","year":"2014","unstructured":"Walsh, D. A. & McWilliams, D. F. Mechanisms, impact and management of pain in rheumatoid arthritis. Nat. Rev. Rheumatol. 10, 581\u2013592 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1155_CR32","doi-asserted-by":"crossref","first-page":"105399","DOI":"10.1016\/j.jbspin.2022.105399","volume":"89","author":"AP Trouvin","year":"2022","unstructured":"Trouvin, A. P., Attal, N. & Perrot, S. Assessing central sensitization with quantitative sensory testing in inflammatory rheumatic diseases: a systematic review. Jt. Bone Spine 89, 105399\u2013105399 (2022).","journal-title":"Jt. Bone Spine"},{"key":"1155_CR33","unstructured":"Todd, A. J. & Koerber, H. R. in Wall & Melzack\u2019s Textbook of Pain. 6th edn. (eds McMahon, S. B., Koltzenburg, M., Tracey, I., & Turk, D. C.) 77\u201393 (Elsevier, 2013)."},{"key":"1155_CR34","doi-asserted-by":"crossref","unstructured":"Smith, E. S. J. & Lee, M. C. in Cambridge Textbook of Neuroscience for Psychiatrists. (eds Lynall, M.-E., Jones, P. B., & Stahl, S. M.) 171\u2013176 (Cambridge Univ. Press, 2023).","DOI":"10.1017\/9781911623137.028"},{"key":"1155_CR35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1139\/y91-096","volume":"69","author":"AI Basbaum","year":"1991","unstructured":"Basbaum, A. I. & Levine, J. D. The contribution of the nervous system to inflammation and inflammatory disease. Can. J. Physiol. Pharmacol. 69, 647\u2013651 (1991).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"1155_CR36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41583-021-00555-4","volume":"23","author":"S Udit","year":"2022","unstructured":"Udit, S., Blake, K. & Chiu, I. M. Somatosensory and autonomic neuronal regulation of the immune response. Nat. Rev. Neurosci. 23, 157\u2013171 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"1155_CR37","unstructured":"Solandt, D. Y. in Electrical Signs of Nervous Activity. (eds Erlanger, J. and Gasser, H. S.) (Univ. Pennsylvania Press, 1937)."},{"key":"1155_CR38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(93)90183-P","volume":"55","author":"HG Schaible","year":"1993","unstructured":"Schaible, H. G. & Grubb, B. D. Afferent and spinal mechanisms of joint pain. Pain 55, 5\u201354 (1993).","journal-title":"Pain"},{"key":"1155_CR39","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916636387","volume":"12","author":"I da Silva Serra","year":"2016","unstructured":"da Silva Serra, I., Husson, Z., Bartlett, J. D. & Smith, E. S. J. Characterization of cutaneous and articular sensory neurons. Mol. Pain. 12, 1744806916636387 (2016).","journal-title":"Mol. Pain."},{"key":"1155_CR40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1302\/0301-620X.90B2.19808","volume":"90","author":"T Nakajima","year":"2008","unstructured":"Nakajima, T. et al. The characteristics of dorsal-root ganglia and sensory innervation of the hip in rats. J. Bone Jt. Surg. Br. 90, 254\u2013257 (2008).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"1155_CR41","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.joca.2013.06.018","volume":"21","author":"A Eitner","year":"2013","unstructured":"Eitner, A., Pester, J., Nietzsche, S., Hofmann, G. O. & Schaible, H. G. The innervation of synovium of human osteoarthritic joints in comparison with normal rat and sheep synovium. Osteoarthritis Cartilage 21, 1383\u20131391 (2013).","journal-title":"Osteoarthritis Cartilage"},{"key":"1155_CR42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.joca.2019.07.012","volume":"27","author":"AM Obeidat","year":"2019","unstructured":"Obeidat, A. M., Miller, R. E., Miller, R. J. & Malfait, A. M. The nociceptive innervation of the normal and osteoarthritic mouse knee. Osteoarthritis Cartilage 27, 1669\u20131679 (2019).","journal-title":"Osteoarthritis Cartilage"},{"key":"1155_CR43","volume":"20","author":"Y Lin","year":"2019","unstructured":"Lin, Y., Zhang, K., Li, Q., Li, J. & Xu, B. Innervation of nociceptors in intact human menisci along the longitudinal axis: semi-quantitative histological evaluation and clinical implications. BMC Musculoskelet. Disord. 20, 338 (2019).","journal-title":"BMC Musculoskelet. Disord."},{"key":"1155_CR44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-1331.2005.01260.x","volume":"12","author":"G Lauria","year":"2005","unstructured":"Lauria, G. et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur. J. Neurol. 12, 747\u2013758 (2005).","journal-title":"Eur. J. Neurol."},{"key":"1155_CR45","first-page":"983","volume":"165","author":"D Choi","year":"2024","unstructured":"Choi, D. et al. Spontaneous activity in peripheral sensory nerves: a systematic review. Pain 165, 983\u2013996 (2024).","journal-title":"Pain"},{"key":"1155_CR46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(83)90379-7","volume":"272","author":"RE Coggeshall","year":"1983","unstructured":"Coggeshall, R. E., Hong, K. A., Langford, L. A., Schaible, H. G. & Schmidt, R. F. Discharge characteristics of fine medial articular afferents at rest and during passive movements of inflamed knee joints. Brain Res. 272, 185\u2013188 (1983).","journal-title":"Brain Res."},{"key":"1155_CR47","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/j.pain.0000000000001890","volume":"161","author":"S Chakrabarti","year":"2020","unstructured":"Chakrabarti, S. et al. Sensitization of knee-innervating sensory neurons by tumor necrosis factor-\u03b1-activated fibroblast-like synoviocytes: an in vitro, coculture model of inflammatory pain. Pain 161, 2129\u20132141 (2020).","journal-title":"Pain"},{"key":"1155_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00238950","volume":"58","author":"G Guilbaud","year":"1985","unstructured":"Guilbaud, G., Iggo, A. & Tegn\u00e9r, R. Sensory receptors in ankle joint capsules of normal and arthritic rats. Exp. Brain Res. 58, 29\u201340 (1985).","journal-title":"Exp. Brain Res."},{"key":"1155_CR49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/jn.1986.55.4.635","volume":"55","author":"P Grigg","year":"1986","unstructured":"Grigg, P., Schaible, H. G. & Schmidt, R. F. Mechanical sensitivity of group III and IV afferents from posterior articular nerve in normal and inflamed cat knee. J. Neurophysiol. 55, 635\u2013643 (1986).","journal-title":"J. Neurophysiol."},{"key":"1155_CR50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1681.1996.tb02579.x","volume":"23","author":"M Michaelis","year":"1996","unstructured":"Michaelis, M., H\u00e4bler, H.-J. & J\u00e4nig, W. Silent afferents: a separate class of primary afferents? Clin. Exp. Pharmacol. Physiol. 23, 99\u2013105 (1996).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1155_CR51","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.celrep.2017.11.066","volume":"21","author":"V Prato","year":"2017","unstructured":"Prato, V. et al. Functional and molecular characterization of mechanoinsensitive \u201cSilent\u201d nociceptors. Cell Rep. 21, 3102\u20133115 (2017).","journal-title":"Cell Rep."},{"key":"1155_CR52","doi-asserted-by":"crossref","first-page":"eabj8186","DOI":"10.1126\/scitranslmed.abj8186","volume":"14","author":"D Tavares-Ferreira","year":"2022","unstructured":"Tavares-Ferreira, D. et al. Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors. Sci. Transl. Med. 14, eabj8186 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1155_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.sjpain.2014.01.002","volume":"5","author":"AD Farmer","year":"2014","unstructured":"Farmer, A. D. & Aziz, Q. Mechanisms of visceral pain in health and functional gastrointestinal disorders. Scand. J. Pain. 5, 51\u201360 (2014).","journal-title":"Scand. J. Pain."},{"key":"1155_CR54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/j.pain.0000000000001692","volume":"161","author":"SM Brierley","year":"2020","unstructured":"Brierley, S. M. et al. Innate immune response to bacterial urinary tract infection sensitises high-threshold bladder afferents and recruits silent nociceptors. Pain 161, 202\u2013210 (2020).","journal-title":"Pain"},{"key":"1155_CR55","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/j.pain.0000000000001880","volume":"161","author":"MW Kucharczyk","year":"2020","unstructured":"Kucharczyk, M. W. et al. The impact of bone cancer on the peripheral encoding of mechanical pressure stimuli. Pain 161, 1894\u20131905 (2020).","journal-title":"Pain"},{"key":"1155_CR56","unstructured":"Schaible, H.-G. in Wall & Melzack\u2019s Textbook of Pain. (eds McMahon, S. B., Koltzenburg, M., Tracey, I. & Turk, D. C.) 6th edn, 77\u201393 (Elsevier, 2013)."},{"key":"1155_CR57","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1073\/pnas.1011774108","volume":"108","author":"A Hess","year":"2011","unstructured":"Hess, A. et al. Blockade of TNF-\u03b1 rapidly inhibits pain responses in the central nervous system. Proc. Natl Acad. Sci. USA 108, 3731\u20133736 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1155_CR58","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.23608","volume":"58","author":"MK Boettger","year":"2008","unstructured":"Boettger, M. K. et al. Antinociceptive effects of tumor necrosis factor \u03b1 neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum. 58, 2368\u20132378 (2008).","journal-title":"Arthritis Rheum."},{"key":"1155_CR59","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/art.34384","volume":"64","author":"E Vazquez","year":"2012","unstructured":"Vazquez, E. et al. Spinal interleukin-6 is an amplifier of arthritic pain in the rat. Arthritis Rheum. 64, 2233\u20132242 (2012).","journal-title":"Arthritis Rheum."},{"key":"1155_CR60","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13075-015-0858-0","volume":"17","author":"M Ebbinghaus","year":"2015","unstructured":"Ebbinghaus, M. et al. Interleukin-6-dependent influence of nociceptive sensory neurons on antigen-induced arthritis. Arthritis Res. Ther. 17, 334 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR61","doi-asserted-by":"publisher","unstructured":"Krock, E., Jurczak, A. & Svensson, C. I. Pain pathogenesis in rheumatoid arthritis \u2014 what have we learned from animal models? Pain 159, https:\/\/doi.org\/10.1097\/j.pain.0000000000001333 (2018).","DOI":"10.1097\/j.pain.0000000000001333"},{"key":"1155_CR62","volume":"14","author":"M Jung","year":"2023","unstructured":"Jung, M. et al. Cross-species transcriptomic atlas of dorsal root ganglia reveals species-specific programs for sensory function. Nat. Commun. 14, 366 (2023).","journal-title":"Nat. Commun."},{"key":"1155_CR63","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.it.2017.12.003","volume":"39","author":"AD Cook","year":"2018","unstructured":"Cook, A. D., Christensen, A. D., Tewari, D., McMahon, S. B. & Hamilton, J. A. Immune cytokines and their receptors in inflammatory pain. Trends Immunol. 39, 240\u2013255 (2018).","journal-title":"Trends Immunol."},{"key":"1155_CR64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn3946","volume":"16","author":"SB McMahon","year":"2015","unstructured":"McMahon, S. B., Russa, F. L. & Bennett, D. L. H. Crosstalk between the nociceptive and immune systems in host defence and disease. Nat. Rev. Neurosci. 16, 389\u2013402 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"1155_CR65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-neuro-072116-031121","volume":"40","author":"F Denk","year":"2017","unstructured":"Denk, F., Bennett, D. L. & McMahon, S. B. Nerve growth factor and pain mechanisms. Annu. Rev. Neurosci. 40, 307\u2013325 (2017).","journal-title":"Annu. Rev. Neurosci."},{"key":"1155_CR66","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/art.41674","volume":"73","author":"MC Hochberg","year":"2021","unstructured":"Hochberg, M. C. et al. Long-term safety and efficacy of subcutaneous tanezumab versus nonsteroidal antiinflammatory drugs for hip or knee osteoarthritis: a randomized trial. Arthritis Rheumatol. 73, 1167\u20131177 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1155_CR67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","volume":"6","author":"F Marchand","year":"2005","unstructured":"Marchand, F., Perretti, M. & McMahon, S. B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6, 521\u2013532 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"1155_CR68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","volume":"19","author":"P Baral","year":"2019","unstructured":"Baral, P., Udit, S. & Chiu, I. M. Pain and immunity: implications for host defence. Nat. Rev. Immunol. 19, 433\u2013447 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1155_CR69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","volume":"11","author":"M Calvo","year":"2012","unstructured":"Calvo, M., Dawes, J. M. & Bennett, D. L. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 11, 629\u2013642 (2012).","journal-title":"Lancet Neurol."},{"key":"1155_CR70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2015.00571","volume":"6","author":"CA Roberts","year":"2015","unstructured":"Roberts, C. A., Dickinson, A. K. & Taams, L. S. The interplay between monocytes\/macrophages and CD4+ T cell subsets in rheumatoid arthritis. Front. Immunol. 6, 571 (2015).","journal-title":"Front. Immunol."},{"key":"1155_CR71","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000527","volume":"3","author":"M Kurowska-Stolarska","year":"2017","unstructured":"Kurowska-Stolarska, M. & Alivernini, S. Synovial tissue macrophages: friend or foe? RMD Open. 3, e000527 (2017).","journal-title":"RMD Open."},{"key":"1155_CR72","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/art.39134","volume":"67","author":"J Massier","year":"2015","unstructured":"Massier, J., Eitner, A., Segond von Banchet, G. & Schaible, H.-G. Effects of differently activated rodent macrophages on sensory neurons: implications for arthritis pain. Arthritis Rheumatol. 67, 2263\u20132272 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1155_CR73","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295\u20131306 (2020).","journal-title":"Nat. Med."},{"key":"1155_CR74","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","volume":"623","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616\u2013624 (2023).","journal-title":"Nature"},{"key":"1155_CR75","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580\u20131588 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR76","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2019-215337","volume":"78","author":"R Toes","year":"2019","unstructured":"Toes, R. & Pisetsky, D. S. Pathogenic effector functions of ACPA: where do we stand? Ann. Rheum. Dis. 78, 716\u2013721 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00281-017-0627-z","volume":"39","author":"V Derksen","year":"2017","unstructured":"Derksen, V., Huizinga, T. W. J. & van der Woude, D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin. Immunopathol. 39, 437\u2013446 (2017).","journal-title":"Semin. Immunopathol."},{"key":"1155_CR78","doi-asserted-by":"crossref","unstructured":"el Bannoudi, H., Ioan-Facsinay, A. & Toes, R. E. M. in Fc Receptors. (eds Daeron, M. & Nimmerjahn, F.) 303\u2013319 (Springer, 2014).","DOI":"10.1007\/978-3-319-07911-0_14"},{"key":"1155_CR79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","volume":"16","author":"H Ji","year":"2002","unstructured":"Ji, H. et al. Arthritis critically dependent on innate immune system players. Immunity 16, 157\u2013168 (2002).","journal-title":"Immunity"},{"key":"1155_CR80","doi-asserted-by":"crossref","first-page":"178ra140","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur, R. et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5, 178ra140 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1155_CR81","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","volume":"75","author":"G Wigerblad","year":"2016","unstructured":"Wigerblad, G. et al. Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism. Ann. Rheum. Dis. 75, 730\u2013738 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR82","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/j.pain.0000000000002543","volume":"163","author":"A Jurczak","year":"2022","unstructured":"Jurczak, A. et al. Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitization. Pain 163, 1542\u20131559 (2022).","journal-title":"Pain"},{"key":"1155_CR83","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1177\/147323001003800402","volume":"38","author":"P Taylor","year":"2010","unstructured":"Taylor, P. et al. Patient perceptions concerning pain management in the treatment of rheumatoid arthritis. J. Int. Med. Res. 38, 1213\u20131224 (2010).","journal-title":"J. Int. Med. Res."},{"key":"1155_CR84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13075-019-1833-y","volume":"21","author":"I Hafstr\u00f6m","year":"2019","unstructured":"Hafstr\u00f6m, I., Ajeganova, S., Forslind, K. & Svensson, B. Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort. Arthritis Res. Ther. 21, 45 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR85","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard-2023-224492","volume":"82","author":"YY Qiu","year":"2023","unstructured":"Qiu, Y. Y. et al. Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis. Ann. Rheum. Dis. 82, 1638\u20131640 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR86","volume":"14","author":"Y He","year":"2023","unstructured":"He, Y. et al. A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis. Nat. Commun. 14, 691 (2023).","journal-title":"Nat. Commun."},{"key":"1155_CR87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.42679","volume":"76","author":"AM Gomez","year":"2024","unstructured":"Gomez, A. M. et al. Anti-citrullinated protein antibodies with multiple specificities ameliorate collagen antibody-induced arthritis in a time-dependent manner. Arthritis Rheumatol. 76, 181\u2013191 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1155_CR88","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard-2022-223417","volume":"82","author":"B Raposo","year":"2023","unstructured":"Raposo, B. et al. Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development. Ann. Rheum. Dis. 82, 724\u2013726 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13075-018-1631-y","volume":"20","author":"LT Donlin","year":"2018","unstructured":"Donlin, L. T. et al. Methods for high-dimensional analysis of cells dissociated from cryopreserved synovial tissue. Arthritis Res. Ther. 20, 139 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR90","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928\u2013942 (2019).","journal-title":"Nat. Immunol."},{"key":"1155_CR91","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48620-7","volume":"15","author":"K Weinand","year":"2024","unstructured":"Weinand, K. et al. The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis. Nat. Commun. 15, 4650 (2024).","journal-title":"Nat. Commun."},{"key":"1155_CR92","doi-asserted-by":"publisher","unstructured":"Inamo, J. et al. Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. Preprint at bioRxiv 2023.2007.2003.547507, https:\/\/doi.org\/10.1101\/2023.07.03.547507 (2023).","DOI":"10.1101\/2023.07.03.547507"},{"key":"1155_CR93","doi-asserted-by":"crossref","first-page":"109707","DOI":"10.1016\/j.isci.2024.109707","volume":"27","author":"SG Edalat","year":"2024","unstructured":"Edalat, S. G. et al. Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol. iScience 27, 109707 (2024).","journal-title":"iScience"},{"key":"1155_CR94","volume":"10","author":"MQ Nguyen","year":"2021","unstructured":"Nguyen, M. Q., von Buchholtz, L. J., Reker, A. N., Ryba, N. J. P. & Davidson, S. Single-nucleus transcriptomic analysis of human dorsal root ganglion neurons. eLife 10, e71752 (2021).","journal-title":"eLife"},{"key":"1155_CR95","first-page":"749","volume":"146","author":"PR Ray","year":"2022","unstructured":"Ray, P. R. et al. RNA profiling of human dorsal root ganglia reveals sex differences in mechanisms promoting neuropathic pain. Brain 146, 749\u2013766 (2022).","journal-title":"Brain"},{"key":"1155_CR96","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/s41467-023-37518-5","volume":"14","author":"TA Nees","year":"2023","unstructured":"Nees, T. A. et al. Role of TMEM100 in mechanically insensitive nociceptor un-silencing. Nat. Commun. 14, 1889 (2023).","journal-title":"Nat. Commun."},{"key":"1155_CR97","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","volume":"21","author":"S Davidson","year":"2021","unstructured":"Davidson, S. et al. Fibroblasts as immune regulators in infection, inflammation and cancer. Nat. Rev. Immunol. 21, 704\u2013717 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1155_CR98","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246\u2013251 (2019).","journal-title":"Nature"},{"key":"1155_CR99","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","volume":"54","author":"J Fri\u0161\u010di\u0107","year":"2021","unstructured":"Fri\u0161\u010di\u0107, J. et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54, 1002\u20131021.e10 (2021).","journal-title":"Immunity"},{"key":"1155_CR100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjos-2021-100235","volume":"6","author":"N Shinotsuka","year":"2022","unstructured":"Shinotsuka, N. & Denk, F. Fibroblasts: the neglected cell type in peripheral sensitisation and chronic pain? A review based on a systematic search of the literature. BMJ Open. Sci. 6, e100235 (2022).","journal-title":"BMJ Open. Sci."},{"key":"1155_CR101","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","volume":"593","author":"MB Buechler","year":"2021","unstructured":"Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575\u2013579 (2021).","journal-title":"Nature"},{"key":"1155_CR102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.medj.2022.05.002","volume":"3","author":"I Korsunsky","year":"2022","unstructured":"Korsunsky, I. et al. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. Med 3, 481\u2013518.e414 (2022).","journal-title":"Med"},{"key":"1155_CR103","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.1913444117","volume":"117","author":"P Singhmar","year":"2020","unstructured":"Singhmar, P. et al. The fibroblast-derived protein PI16 controls neuropathic pain. Proc. Natl Acad. Sci. 117, 5463\u20135471 (2020).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1155_CR104","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbi.2023.06.011","volume":"112","author":"R Garrity","year":"2023","unstructured":"Garrity, R. et al. Fibroblast-derived PI16 sustains inflammatory pain via regulation of CD206+ myeloid cells. Brain Behav. Immun. 112, 220\u2013234 (2023).","journal-title":"Brain Behav. Immun."},{"key":"1155_CR105","doi-asserted-by":"crossref","first-page":"eadk3506","DOI":"10.1126\/scitranslmed.adk3506","volume":"16","author":"Z Bai","year":"2024","unstructured":"Bai, Z. et al. Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis. Sci. Transl. Med. 16, eadk3506 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1155_CR106","unstructured":"British Society for Rheumatology. Rheumatology workforce: a crisis in numbers. https:\/\/rheumatology.org.uk\/Portals\/0\/Documents\/Policy\/Reports\/BSR-workforce-report-crisis-numbers.pdf (2021)."},{"key":"1155_CR107","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/ard.62.7.611","volume":"62","author":"E Lindqvist","year":"2003","unstructured":"Lindqvist, E., Jonsson, K., Saxne, T. & Eberhardt, K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann. Rheum. Dis. 62, 611\u2013616 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41584-023-01062-9","volume":"20","author":"Z Szekanecz","year":"2024","unstructured":"Szekanecz, Z. et al. Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat. Rev. Rheumatol. 20, 101\u2013115 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1155_CR109","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"M-A Fitzcharles","year":"2021","unstructured":"Fitzcharles, M.-A. et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397, 2098\u20132110 (2021).","journal-title":"Lancet"},{"key":"1155_CR110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s40744-021-00357-1","volume":"8","author":"EA Holdsworth","year":"2021","unstructured":"Holdsworth, E. A. et al. Biologic and targeted synthetic DMARD utilization in the United States: Adelphi real world disease specific programme for rheumatoid arthritis. Rheumatol. Ther. 8, 1637\u20131649 (2021).","journal-title":"Rheumatol. Ther."},{"key":"1155_CR111","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg, S. R. et al. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N. Engl. J. Med. 386, 316\u2013326 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1155_CR112","unstructured":"FDA. Janus Kinase (JAK) Inhibitors: Drug Safety Communication \u2014 FDA Requires Warnings about Increased Risk of Serious Heart-related Events, Cancer, Blood Clots, and Death. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/janus-kinase-jak-inhibitors-drug-safety-communication-fda-requires-warnings-about-increased-risk (2021)."},{"key":"1155_CR113","unstructured":"European Medicines Agency. Janus Kinase inhibitors (JAKi). Article-20 procedure \u2014 EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders. EMA\/142279\/2023 https:\/\/europa.eu\/!BkjJNH (2023)."},{"key":"1155_CR114","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/art.41032","volume":"71","author":"R Fleischmann","year":"2019","unstructured":"Fleischmann, R. et al. Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III, double-blind, randomized controlled trial. Arthritis Rheumatol. 71, 1788\u20131800 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1155_CR115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","volume":"376","author":"PC Taylor","year":"2017","unstructured":"Taylor, P. C. et al. Baricitinib versus placebo or adalimumab in rheumatoid arthritis. N. Engl. J. Med. 376, 652\u2013662 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1155_CR116","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/jcm8091394","volume":"8","author":"B Fautrel","year":"2019","unstructured":"Fautrel, B. et al. Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM. J. Clin. Med. 8, 1394 (2019).","journal-title":"J. Clin. Med."},{"key":"1155_CR117","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1523\/JNEUROSCI.3055-19.2020","volume":"40","author":"P Barrag\u00e1n-Iglesias","year":"2020","unstructured":"Barrag\u00e1n-Iglesias, P. et al. Type I interferons act directly on nociceptors to produce pain sensitization: implications for viral infection-induced pain. J. Neurosci. 40, 3517\u20133532 (2020).","journal-title":"J. Neurosci."},{"key":"1155_CR118","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13075-024-03354-1","volume":"26","author":"K Makabe","year":"2024","unstructured":"Makabe, K. et al. Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6\/JAK\/STAT3 pathway and CSF-1 expression in dorsal root ganglion neurons. Arthritis Res. Ther. 26, 121 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR119","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13311-020-00887-6","volume":"17","author":"K Bannister","year":"2020","unstructured":"Bannister, K. & Dickenson, A. H. Central nervous system targets: supraspinal mechanisms of analgesia. Neurotherapeutics 17, 839\u2013845 (2020).","journal-title":"Neurotherapeutics"},{"key":"1155_CR120","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/j.pain.0000000000000863","volume":"158","author":"I Tracey","year":"2017","unstructured":"Tracey, I. Neuroimaging mechanisms in pain: from discovery to translation. Pain 158, S115\u2013S122 (2017).","journal-title":"Pain"},{"key":"1155_CR121","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ejp.1875","volume":"26","author":"S Elbers","year":"2022","unstructured":"Elbers, S. et al. Longitudinal outcome evaluations of Interdisciplinary Multimodal Pain Treatment programmes for patients with chronic primary musculoskeletal pain: a systematic review and meta-analysis. Eur. J. Pain. 26, 310\u2013335 (2022).","journal-title":"Eur. J. Pain."},{"key":"1155_CR122","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/art.24276","volume":"61","author":"W H\u00e4user","year":"2009","unstructured":"H\u00e4user, W., Bernardy, K., Arnold, B., Offenb\u00e4cher, M. & Schiltenwolf, M. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum. 61, 216\u2013224 (2009).","journal-title":"Arthritis Rheum."},{"key":"1155_CR123","doi-asserted-by":"crossref","first-page":"5960987","DOI":"10.1155\/2016\/5960987","volume":"2016","author":"SR Fashler","year":"2016","unstructured":"Fashler, S. R. et al. Systematic review of multidisciplinary chronic pain treatment facilities. Pain. Res. Manag. 2016, 5960987 (2016).","journal-title":"Pain. Res. Manag."},{"key":"1155_CR124","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-06114-y","volume":"21","author":"S Deslauriers","year":"2021","unstructured":"Deslauriers, S. et al. The burden of waiting to access pain clinic services: perceptions and experiences of patients with rheumatic conditions. BMC Health Serv. Res. 21, 160 (2021).","journal-title":"BMC Health Serv. Res."},{"key":"1155_CR125","volume":"19","author":"TH N\u00f8st","year":"2019","unstructured":"N\u00f8st, T. H. & Steinsbekk, A. \u2018A lifebuoy\u2019 and \u2018a waste of time\u2019: patients\u2019 varying experiences of multidisciplinary pain centre treatment \u2014 a qualitative study. BMC Health Serv. Res. 19, 1015 (2019).","journal-title":"BMC Health Serv. Res."},{"key":"1155_CR126","doi-asserted-by":"crossref","DOI":"10.1186\/ar4174","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford, L. J. Use of NSAIDs in treating patients with arthritis. Arthritis Res. Ther. 15, S2 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"1155_CR127","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2008.096362","volume":"68","author":"H Osnes-Ringen","year":"2009","unstructured":"Osnes-Ringen, H., Kvien, T. K., Henriksen, J. E., Mowinckel, P. & Dagfinrud, H. Orthopaedic surgery in 255 patients with inflammatory arthropathies: longitudinal effects on pain, physical function and health-related quality of life. Ann. Rheum. Dis. 68, 1596\u20131601 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR128","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/acr.22090","volume":"65","author":"JA Singh","year":"2013","unstructured":"Singh, J. A. & Lewallen, D. G. Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: a cohort study. Arthritis Care Res. 65, 1936\u20131941 (2013).","journal-title":"Arthritis Care Res."},{"key":"1155_CR129","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/rheumatology\/kez303","volume":"59","author":"A Schrepf","year":"2019","unstructured":"Schrepf, A. et al. Top down or bottom up? An observational investigation of improvement in fibromyalgia symptoms following hip and knee replacement. Rheumatology 59, 594\u2013602 (2019).","journal-title":"Rheumatology"},{"key":"1155_CR130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nbt.2249","volume":"30","author":"SM Chambers","year":"2012","unstructured":"Chambers, S. M. et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol. 30, 715\u2013720 (2012).","journal-title":"Nat. Biotechnol."},{"key":"1155_CR131","doi-asserted-by":"crossref","first-page":"eadh3839","DOI":"10.1126\/scitranslmed.adh3839","volume":"15","author":"J Perez-Sanchez","year":"2023","unstructured":"Perez-Sanchez, J. et al. A humanized chemogenetic system inhibits murine pain-related behavior and hyperactivity in human sensory neurons. Sci. Transl. Med. 15, eadh3839 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1155_CR132","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.stemcr.2023.03.006","volume":"18","author":"T Deng","year":"2023","unstructured":"Deng, T. et al. Scalable generation of sensory neurons from human pluripotent stem cells. Stem Cell Rep. 18, 1030\u20131047 (2023).","journal-title":"Stem Cell Rep."},{"key":"1155_CR133","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","volume":"582","author":"K Wei","year":"2020","unstructured":"Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259\u2013264 (2020).","journal-title":"Nature"},{"key":"1155_CR134","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2665-9913(23)00190-X","volume":"5","author":"PA Johnson","year":"2023","unstructured":"Johnson, P. A. et al. Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases. Lancet Rheumatol. 5, e553\u2013e563 (2023).","journal-title":"Lancet Rheumatol."},{"key":"1155_CR135","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1039\/C4IB00035H","volume":"6","author":"E Neto","year":"2014","unstructured":"Neto, E. et al. Sensory neurons and osteoblasts: close partners in a microfluidic platform. Integr. Biol. 6, 586\u2013595 (2014).","journal-title":"Integr. Biol."},{"key":"1155_CR136","doi-asserted-by":"publisher","unstructured":"Molina-Mart\u00ednez, B. et al. A multimodal 3D neuro-microphysiological system with neurite-trapping microelectrodes. Biofabrication 14, https:\/\/doi.org\/10.1088\/1758-5090\/ac463b (2022).","DOI":"10.1088\/1758-5090\/ac463b"},{"key":"1155_CR137","doi-asserted-by":"crossref","first-page":"025013","DOI":"10.1088\/1758-5090\/ad218a","volume":"16","author":"M van der Moolen","year":"2024","unstructured":"van der Moolen, M. et al. Cancer-mediated axonal guidance of sensory neurons in a microelectrode-based innervation MPS. Biofabrication 16, 025013 (2024).","journal-title":"Biofabrication"},{"key":"1155_CR138","doi-asserted-by":"publisher","unstructured":"Chisholm, K. I., Khovanov, N., Lopes, D. M., La Russa, F. & McMahon, S. B. Large scale in vivo recording of sensory neuron activity with GCaMP6. eNeuro 5, https:\/\/doi.org\/10.1523\/ENEURO.0417-17.2018 (2018).","DOI":"10.1523\/ENEURO.0417-17.2018"},{"key":"1155_CR139","first-page":"1131","volume":"165","author":"S Ingram","year":"2024","unstructured":"Ingram, S. et al. Assessing spontaneous sensory neuron activity using in vivo calcium imaging. Pain 165, 1131\u20131141 (2024).","journal-title":"Pain"},{"key":"1155_CR140","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1523\/JNEUROSCI.3565-17.2018","volume":"38","author":"AM Cowie","year":"2018","unstructured":"Cowie, A. M., Moehring, F., O\u2019Hara, C. & Stucky, C. L. Optogenetic inhibition of CGRP\u03b1 sensory neurons reveals their distinct roles in neuropathic and incisional pain. J. Neurosci. 38, 5807\u20135825 (2018).","journal-title":"J. Neurosci."},{"key":"1155_CR141","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbi.2023.09.023","volume":"115","author":"N Soliman","year":"2024","unstructured":"Soliman, N. & Denk, F. Practical approaches to improving translatability and reproducibility in preclinical pain research. Brain Behav. Immun. 115, 38\u201342 (2024).","journal-title":"Brain Behav. Immun."},{"key":"1155_CR142","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41583-021-00536-7","volume":"23","author":"KE Sadler","year":"2022","unstructured":"Sadler, K. E., Mogil, J. S. & Stucky, C. L. Innovations and advances in modelling and measuring pain in animals. Nat. Rev. Neurosci. 23, 70\u201385 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"1155_CR143","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/j.pain.0000000000001749","volume":"161","author":"CA Federico","year":"2020","unstructured":"Federico, C. A., Mogil, J. S., Ramsay, T., Fergusson, D. A. & Kimmelman, J. A systematic review and meta-analysis of pregabalin preclinical studies. Pain 161, 684\u2013693 (2020).","journal-title":"Pain"},{"key":"1155_CR144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000243","volume":"17","author":"GL Currie","year":"2019","unstructured":"Currie, G. L. et al. Animal models of chemotherapy-induced peripheral neuropathy: a machine-assisted systematic review and meta-analysis. PLoS Biol. 17, e3000243 (2019).","journal-title":"PLoS Biol."},{"key":"1155_CR145","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41592-022-01615-y","volume":"19","author":"J Vollert","year":"2022","unstructured":"Vollert, J. et al. The EQIPD framework for rigor in the design, conduct, analysis and documentation of animal experiments. Nat. Methods 19, 1334\u20131337 (2022).","journal-title":"Nat. Methods"},{"key":"1155_CR146","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 18, e3000411 (2020).","journal-title":"PLoS Biol."},{"key":"1155_CR147","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jesp.2017.09.004","volume":"74","author":"C Albers","year":"2018","unstructured":"Albers, C. & Lakens, D. When power analyses based on pilot data are biased: inaccurate effect size estimators and follow-up bias. J. Exp. Soc. Psychol. 74, 187\u2013195 (2018).","journal-title":"J. Exp. Soc. Psychol."},{"key":"1155_CR148","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","volume":"123","author":"R Rolke","year":"2006","unstructured":"Rolke, R. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123, 231\u2013243 (2006).","journal-title":"Pain"},{"key":"1155_CR149","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jnnp.42.5.422","volume":"42","author":"U Lindblom","year":"1979","unstructured":"Lindblom, U. & Verrillo, R. T. Sensory functions in chronic neuralgia. J. Neurol. Neurosurg. Psychiatry 42, 422\u2013435 (1979).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1155_CR150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ejp.1140","volume":"22","author":"L Arendt-Nielsen","year":"2018","unstructured":"Arendt-Nielsen, L. et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur. J. Pain. 22, 216\u2013241 (2018).","journal-title":"Eur. J. Pain."},{"key":"1155_CR151","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1515\/sjpain-2022-0088","volume":"22","author":"M Schmelz","year":"2022","unstructured":"Schmelz, M. Lessons learned \u2014 moving on from QST sensory profiles. Scand. J. Pain. 22, 670\u2013672 (2022).","journal-title":"Scand. J. Pain."},{"key":"1155_CR152","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/brain\/awab048","volume":"144","author":"SJ Middleton","year":"2021","unstructured":"Middleton, S. J. et al. Studying human nociceptors: from fundamentals to clinic. Brain 144, 1312\u20131335 (2021).","journal-title":"Brain"},{"key":"1155_CR153","volume":"5","author":"M Reimer","year":"2020","unstructured":"Reimer, M. et al. Sensory bedside testing: a simple stratification approach for sensory phenotyping. Pain. Rep. 5, e820 (2020).","journal-title":"Pain. Rep."},{"key":"1155_CR154","doi-asserted-by":"crossref","first-page":"e000428","DOI":"10.1136\/rmdopen-2016-000428","volume":"3","author":"MA D\u2019Agostino","year":"2017","unstructured":"D\u2019Agostino, M. A. et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce \u2014 part 1: definition and development of a standardised, consensus-based scoring system. RMD Open. 3, e000428\u2013e000428 (2017).","journal-title":"RMD Open."},{"key":"1155_CR155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/art.22461","volume":"57","author":"E Naredo","year":"2007","unstructured":"Naredo, E. et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Care Res. 57, 116\u2013124 (2007).","journal-title":"Arthritis Care Res."},{"key":"1155_CR156","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuron.2019.02.019","volume":"101","author":"I Tracey","year":"2019","unstructured":"Tracey, I., Woolf, C. J. & Andrews, N. A. Composite pain biomarker signatures for objective assessment and effective treatment. Neuron 101, 783\u2013800 (2019).","journal-title":"Neuron"},{"key":"1155_CR157","doi-asserted-by":"publisher","unstructured":"Rutter-Locher, Z. et al. A randomised controlled trial of the effect of intra-articular lidocaine on pain scores in inflammatory arthritis. Pain https:\/\/doi.org\/10.1097\/j.pain.0000000000003291 (2024).","DOI":"10.1097\/j.pain.0000000000003291"},{"key":"1155_CR158","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson, J. et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res. 64, 640\u2013647 (2012).","journal-title":"Arthritis Care Res."},{"key":"1155_CR159","volume":"10","author":"PC Taylor","year":"2024","unstructured":"Taylor, P. C. et al. Impact of filgotinib on pain control in the phase 3 FINCH studies. RMD Open. 10, e003839 (2024).","journal-title":"RMD Open."},{"key":"1155_CR160","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1136\/ard-2023-224449","volume":"82","author":"PC Taylor","year":"2023","unstructured":"Taylor, P. C. et al. AB0290 effect of filgotinib on pain in patients with rheumatoid arthritis in the phase 3 FINCH 1, 2 and 3 studies. Ann. Rheum. Dis. 82, 1326\u20131327 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1155_CR161","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3899\/jrheum.181099","volume":"46","author":"A Chiarotto","year":"2019","unstructured":"Chiarotto, A. et al. Pain measurement in rheumatic and musculoskeletal diseases: where to go from here? Report from a special interest group at OMERACT 2018. J. Rheumatol. 46, 1355\u20131359 (2019).","journal-title":"J. Rheumatol."},{"key":"1155_CR162","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand, C. M. & Goronzy, J. J. The immunology of rheumatoid arthritis. Nat. Immunol. 22, 10\u201310 (2021).","journal-title":"Nat. Immunol."},{"key":"1155_CR163","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja, S. N. et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 161, 1976\u20131982 (2020).","journal-title":"Pain"},{"key":"1155_CR164","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/j.pain.0000000000001389","volume":"160","author":"S Perrot","year":"2019","unstructured":"Perrot, S. et al. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain 160, 28\u201337 (2019).","journal-title":"Pain"},{"key":"1155_CR165","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen, S. P., Vase, L. & Hooten, W. M. Chronic pain: an update on burden, best practices, and new advances. Lancet 397, 2082\u20132097 (2021).","journal-title":"Lancet"},{"key":"1155_CR166","unstructured":"IASP. Terminology. https:\/\/www.iasp-pain.org\/resources\/terminology\/ (2011)."},{"key":"1155_CR167","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","volume":"157","author":"E Kosek","year":"2016","unstructured":"Kosek, E. et al. Do we need a third mechanistic descriptor for chronic pain states? Pain 157, 1382\u20131386 (2016).","journal-title":"Pain"},{"key":"1155_CR168","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/acr.25104","volume":"75","author":"AE Murphy","year":"2023","unstructured":"Murphy, A. E., Minhas, D., Clauw, D. J. & Lee, Y. C. Identifying and managing nociplastic pain in individuals with rheumatic diseases: a narrative review. Arthritis Care Res. 75, 2215\u20132222 (2023).","journal-title":"Arthritis Care Res."},{"key":"1155_CR169","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000002662","volume":"163","author":"M Hoegh","year":"2022","unstructured":"Hoegh, M., Schmid, A. B., Hansson, P. & Finnerup, N. B. Not being able to measure what is important, does not make things we can measure important. Pain 163, e963 (2022).","journal-title":"Pain"},{"key":"1155_CR170","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/306686a0","volume":"306","author":"CJ Woolf","year":"1983","unstructured":"Woolf, C. J. Evidence for a central component of post-injury pain hypersensitivity. Nature 306, 686\u2013688 (1983).","journal-title":"Nature"},{"key":"1155_CR171","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"152","author":"CJ Woolf","year":"2011","unstructured":"Woolf, C. J. Central sensitization: implications for the diagnosis and treatment of pain. Pain 152, S2\u2013S15 (2011).","journal-title":"Pain"},{"key":"1155_CR172","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S2665-9913(21)00032-1","volume":"3","author":"J Nijs","year":"2021","unstructured":"Nijs, J. et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 3, e383\u2013e392 (2021).","journal-title":"Lancet Rheumatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01155-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01155-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01155-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T09:08:23Z","timestamp":1729674503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01155-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":172,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1038\/s41584-024-01155-z","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"5 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.L.B. has received research grant funding from Eli Lilly and AstraZeneca. B.W.K. has been an adviser or speaker for AbbVie, Eli-Lilly, Galapagos, Janssen, Novartis, Pfizer and UCB. F.D. receives funding from Ono Pharmaceuticals, is a Scientific Advisor for Cellectricon and is consulting for GSK. L.S.T. has received research funding, speaker or consultancy fees from Sanofi, CESAS Medical, UCB, GSK and AbbVie. C.D.B. has received research grant funding from Janssen, Roche and is an adviser for GSK and AbbVie. He is a founder of Mestag Therapeutics. None of the other authors declares any competing interests relevant to this Review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}